CLINICAL TRIALS PROFILE FOR ICODEXTRIN
✉ Email this page to a colleague
All Clinical Trials for ICODEXTRIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00004987 ↗ | Treatment of Advanced AIDS Patients With Dextrin Sulfate | Unknown status | Steinhart Medical Associates | Phase 1 | 1999-10-01 | The purpose of this study is to look at the safety and effectiveness of dextrin sulfate in AIDS patients who have failed conventional anti-HIV treatment. |
NCT00119990 ↗ | Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis | Terminated | University of Aarhus | N/A | 2006-01-01 | During peritoneal dialysis, water is removed from the body. This sometimes occurs at rates of up to 500 ml/h. During shifts with dialysate with high glucose content, an increase in blood pressure has been described. The effect upon central hemodynamics is unknown. The researchers are investigating the effects of low and high glucose dialysate and icodextrin on cardiac output, stroke volume, pulse rate and blood pressure. The researchers have hypothesized that the effects seen are induced by vasopressin. |
NCT00369096 ↗ | Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina) | Completed | Infociencia S.L | Phase 2 | 2006-09-01 | The purpose of this study is to evaluate whether addition of bemiparin, once daily in icodextrin solution for peritoneal dialysis for 16 weeks, increases the peritoneal capacity for ultrafiltration and/or reduces creatinine transport in peritoneal dialysis patients presenting functional disorders related to ultrafiltration deficit and/or high transport. |
NCT00369096 ↗ | Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina) | Completed | Fundación Renal Iñigo Alvarez De Toledo | Phase 2 | 2006-09-01 | The purpose of this study is to evaluate whether addition of bemiparin, once daily in icodextrin solution for peritoneal dialysis for 16 weeks, increases the peritoneal capacity for ultrafiltration and/or reduces creatinine transport in peritoneal dialysis patients presenting functional disorders related to ultrafiltration deficit and/or high transport. |
NCT00397358 ↗ | Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients | Withdrawn | Baxter Healthcare Corporation | Phase 4 | 2006-11-01 | This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ICODEXTRIN
Condition Name
Clinical Trial Locations for ICODEXTRIN
Trials by Country
Clinical Trial Progress for ICODEXTRIN
Clinical Trial Phase
Clinical Trial Sponsors for ICODEXTRIN
Sponsor Name